Rapidly dissolving paroxetine methanesulfonate formulation containing water soluble or hydrophilic excipient, preferably carbohydrate, used e.g. for treating depression, migraine, anorexia or anxiety

摘要

New medicaments comprise paroxetine methanesulfonate (I) and a carrier including a water-soluble and/or hydrophilic extender (II). Excluded are 20 (or 30) mg tablets containing 20.0 (or 30.0) mg (I) (calculated as free base), 83.34 (or 125.0) mg dicalcium phosphate, 50.67 (or 76.0) mg microcrystalline cellulose, 8.34 (or 12.5) mg sodium starch glycolate and 1.67 (or 2.5) mg magnesium stearate.